Journal profile · Respiratory System
RESPIRATORY RESEARCH
ISSN 1465-9921 · eISSN 1465-993X · BioMed Central · ENGLAND · Bimonthly · Founded 2000
RESPIRATORY RESEARCH: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.71; fully open access; APC about USD 3,590; median 107 days to acceptance (110 articles, last 24 months); community-reported acceptance: easy; 386 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
RESPIRATORY RESEARCH is published by BioMed Central and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, together about 42% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases. As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion. Topics of specific interest include asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory immunology, respiratory physiology, and sleep-related respiratory problems.
From the journal's Aims & Scope
Research area (LetPub): Respiratory System
Editor-in-chief Jens UlrikPublisher website
Editorial board by country: 13 in mainland China (about 8%); most named United States 49, Italy 25, United Kingdom 15, Mainland China 13, Germany 7 (168 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine17.3%
- Asthma and respiratory diseasesMedicine14.4%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine10.3%
- Neonatal Respiratory Health ResearchMedicine7.9%
- Respiratory Support and MechanismsMedicine6%
- Pulmonary Hypertension Research and TreatmentsMedicine5%
- Inhalation and Respiratory Drug DeliveryMedicine3.9%
- Cystic Fibrosis Research AdvancesMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Respiratory System | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Respiratory System | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Respiratory System | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.71LetPub ·
- Impact factor (publisher) 2025
- 5.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.9Publisher website ·
- CiteScore 2026-06
- 8.8LetPub ·
- SJR 2026-06
- 1.61LetPub ·
- SNIP 2026-06
- 1.48LetPub ·
- h-index
- 95LetPub ·
- h-index
- 160OpenAlex ·
- i10-index
- 3,701OpenAlex ·
- 2-year mean citedness
- 5.64OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 355LetPub ·
- Downloads per year (publisher) 2025
- 4,800,000Publisher website ·
Articles by year OpenAlex count · 5,432 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 457 | 457 | 179 |
| 2025 | 386 | 386 | 1,986 |
| 2024 | 448 | 448 | 5,114 |
| 2023 | 321 | 321 | 5,678 |
| 2022 | 383 | 383 | 8,843 |
| 2021 | 323 | 323 | 10,182 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
107 daysMedian, submission to acceptance · P25–P75 80 days – 157 days
- Acceptance to online
- median 14 days (110 articles)
- Submission to online
- median 135 days
- Sample
- 110 articles with submission and acceptance dates (857 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 17 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Submission to publication (journal-reported)
- about 17 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 3,090 / USD 3,590 / GBP 2,790 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,490 / EUR 2,990 / GBP 2,690 | — | — | |
| LetPub | GBP 2,490 / USD 3,290 / EUR 2,790 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
Publisher websiteExcerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2000
- ISSN
- 1465-9921
- Electronic ISSN
- 1465-993X
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about RESPIRATORY RESEARCH
What CAS zone is RESPIRATORY RESEARCH in?
In the 2025 upgraded edition of the CAS Journal Ranking, RESPIRATORY RESEARCH is in Zone 2 of Medicine, and in Zone 2 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of RESPIRATORY RESEARCH?
The latest impact factor listed by LetPub is 5.71; CiteScore 8.8, h-index 160.
How long does peer review take at RESPIRATORY RESEARCH?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 107 days (interquartile range 80–157 days); authors report an average review time of about 17 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of RESPIRATORY RESEARCH based?
Of the 168 board members whose country the journal's board page names, 13 (about 8%) are in mainland China; the countries named most often are United States (49), Italy (25) and United Kingdom (15). Counted from the institutions listed on the board page; for reference only.
Which databases index RESPIRATORY RESEARCH?
According to LetPub and DOAJ records, RESPIRATORY RESEARCH is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase, CAS and CAB Abstracts; that list has not been checked against each database.
Is RESPIRATORY RESEARCH open access, and what is the APC?
RESPIRATORY RESEARCH is a fully open-access journal. APC about USD 3,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .